An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Safety Study of MG1102 in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Effects of OM-174 in Adult Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Genomic Profiling in Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)
- Status
- COMPLETED
- Phase
- PHASE1
MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment
- Status
- COMPLETED
- Phase
- PHASE1
AZD1775 for Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
ST1968 Intravenous (Weekly) in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Anti-EGFR Immunoliposomes in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Tivantinib on the QTC Interval in Cancer Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Dexamethasone Dyspnea Study
- Status
- COMPLETED
- Phase
- PHASE2
A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2